{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:05:34Z","timestamp":1789725934500,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW007124"],"award-info":[{"award-number":["D43TW007124"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI178324"],"award-info":[{"award-number":["R21AI178324"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153152"],"award-info":[{"award-number":["R01AI153152"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is limited evidence on factors affecting tuberculosis (TB) disease development among patients treated for hepatitis C virus (HCV) infection. This study aimed to estimate the incidence of and risk factors for TB disease among patients treated within a national hepatitis C elimination program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cohort study using nationwide electronic TB and HCV databases. The study population included adults who completed HCV treatment between April 2015 and December 2022. We calculated TB disease incidence rate (IR) per 100 000 person-years (PY) with 95% confidence intervals (CIs) overall and by subgroups: advanced liver fibrosis (fibroscan \u2265 F3 or FIB-4 &amp;gt; 3.25), diabetes mellitus (DM) (fasting glucose level\u22657\u2005mmol\/l or self-reported diabetes), and low body mass index (BMI &amp;lt; 18.5). Poisson regression was used to estimate adjusted incidence rate ratio (aIRR) and 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 75 693 individuals who completed treatment for hepatitis C, 544 new TB cases were identified over a median follow-up period of 69 months, corresponding to an IR of 136 per 100 000 PY (95% CI: 125, 148). Individuals with DM had a 53% higher incidence of TB (aIRR = 1.53; 95% CI: 1.09, 2.07) compared to those without. Underweight individuals (BMI &amp;lt; 18.5) had a higher incidence of TB compared with those of normal weight (aIRR 2.8; 95% CI: 1.67, 4.41). Advanced liver fibrosis was not significantly associated with TB disease (aIRR = .95, 95% CI: 0.72, 1.24).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals successfully treated for hepatitis C experienced high incidence of TB disease. Our findings suggest hepatitis C care programs may reduce TB risk by including DM screening and nutritional assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag497","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:42:39Z","timestamp":1787312559000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence of and Risk Factors for Tuberculosis Among Patients Treated for Hepatitis C: a Population-based Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6029-1231","authenticated-orcid":false,"given":"Tamta","family":"Korinteli","sequence":"first","affiliation":[{"name":"The National Center for Lung Health Scientific Research Unit of , Tbilisi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-1204","authenticated-orcid":false,"given":"Nestani","family":"Tukvadze","sequence":"additional","affiliation":[{"name":"The National Center for Lung Health Scientific Research Unit of , Tbilisi ,","place":["Georgia"]},{"name":"Swiss Tropical and Public Health Institute Research Department of , Allschwil ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamuka","family":"Chincharauli","sequence":"additional","affiliation":[{"name":"The National Center for Lung Health Scientific Research Unit of , Tbilisi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-3282","authenticated-orcid":false,"given":"Zaza","family":"Avaliani","sequence":"additional","affiliation":[{"name":"The National Center for Lung Health Scientific Research Unit of , Tbilisi ,","place":["Georgia"]},{"name":"European University Department of Pathology of , Tbilisi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-3858","authenticated-orcid":false,"given":"Maia","family":"Kipiani","sequence":"additional","affiliation":[{"name":"The National Center for Lung Health Scientific Research Unit of , Tbilisi ,","place":["Georgia"]},{"name":"David Tvildiani Medical University Department of Medicine of , Tbilisi ,","place":["Georgia"]},{"name":"The University of Georgia School of Health Science of , Tbilisi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimer","family":"Getia","sequence":"additional","affiliation":[{"name":"National Center for Disease Control and Public Health State Public Health Programs and Regional Management, Department of , Tbilisi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-5796","authenticated-orcid":false,"given":"Matthew J","family":"Magee","sequence":"additional","affiliation":[{"name":"Departments of Global Health and Epidemiology, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3325","authenticated-orcid":false,"given":"Davit","family":"Baliashvili","sequence":"additional","affiliation":[{"name":"BAU Batumi International University School of Graduate and Professional Development, Public Health and Health Policy Program of , Batumi ,","place":["Georgia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026091805312949500_ofag497-B1"},{"key":"2026091805312949500_ofag497-B2","author":"World Health Organisation. Global hepatitis report 2024: action for access in low- and middle-income countries"},{"key":"2026091805312949500_ofag497-B3","first-page":"396","article-title":"High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia","volume":"10","author":"Richards","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026091805312949500_ofag497-B4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.5588\/ijtld.10.0636","article-title":"Hepatitis C virus infection in patients with tuberculosis in Central Brazil","volume":"15","author":"Reis","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026091805312949500_ofag497-B5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/00333549101250S406","article-title":"Prisons as social determinants of hepatitis C virus and tuberculosis infections","volume":"125","author":"Awofeso","year":"2010","journal-title":"Public Health Rep"},{"key":"2026091805312949500_ofag497-B6","doi-asserted-by":"crossref","first-page":"e1328","DOI":"10.1097\/MD.0000000000001328","article-title":"Hepatitis C virus infection is associated with an increased risk of active tuberculosis disease","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026091805312949500_ofag497-B7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/cid\/ciac786","article-title":"Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study","volume":"76","author":"Baliashvili","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026091805312949500_ofag497-B8","doi-asserted-by":"crossref","first-page":"S334","DOI":"10.1093\/infdis\/jiad198","article-title":"Lessons learned from global hepatitis C elimination programs","volume":"229","author":"Handanagic","year":"2024","journal-title":"J Infect Dis"},{"key":"2026091805312949500_ofag497-B9"},{"key":"2026091805312949500_ofag497-B10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.15585\/mmwr.mm7330a1","article-title":"Progress toward the elimination of hepatitis B and hepatitis C in the country of Georgia, April 2015\u2013April 2024","volume":"73","author":"Tohme","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026091805312949500_ofag497-B11"},{"key":"2026091805312949500_ofag497-B12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12889-019-6784-3","article-title":"Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination","volume":"19","author":"Hagan","year":"2019","journal-title":"BMC Public Health"},{"key":"2026091805312949500_ofag497-B13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jiad064","article-title":"Nationwide hepatitis C serosurvey and progress towards hepatitis C virus elimination in the country of Georgia, 2021","volume":"228","author":"Gamkrelidze","year":"2023","journal-title":"J Infect Dis"},{"key":"2026091805312949500_ofag497-B14","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026091805312949500_ofag497-B15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"key":"2026091805312949500_ofag497-B16","author":"World Health Organisation. European health information at your fingertips"},{"key":"2026091805312949500_ofag497-B17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","article-title":"Calculating measures of biological interaction","volume":"20","author":"Andersson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"2026091805312949500_ofag497-B18"},{"key":"2026091805312949500_ofag497-B19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/aje\/kwu095","article-title":"Cirrhosis as a risk factor for tuberculosis infection\u2013a nationwide longitudinal study in Taiwan","volume":"180","author":"Lin","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2026091805312949500_ofag497-B20","doi-asserted-by":"crossref","first-page":"107140","DOI":"10.1016\/j.ijid.2024.107140","article-title":"Tuberculosis and diabetes mellitus: the complexity of the comorbid interactions","volume":"146","author":"Boadu","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2026091805312949500_ofag497-B21","author":"Comorbidity increases the risk of pulmonary tuberculosis: a nested case-control study using multi-source big data | BMC Pulmonary Medicine | Full Text"},{"key":"2026091805312949500_ofag497-B22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/v12010101","article-title":"Hepatitis C virus affects tuberculosis-specific T cells in HIV-negative patients","volume":"12","author":"El-Mokhtar","year":"2020","journal-title":"Viruses"},{"key":"2026091805312949500_ofag497-B23","doi-asserted-by":"crossref","first-page":"e0187967","DOI":"10.1371\/journal.pone.0187967","article-title":"Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Al-Rifai","year":"2017","journal-title":"PLoS One"},{"key":"2026091805312949500_ofag497-B24"},{"key":"2026091805312949500_ofag497-B25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(23)01231-X","article-title":"Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial","volume":"402","author":"Bhargava","year":"2023","journal-title":"Lancet"},{"key":"2026091805312949500_ofag497-B26","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1016\/S2214-109X(25)00021-X","article-title":"A roadmap for integrating nutritional assessment, counselling, and support into the care of people with tuberculosis","volume":"13","author":"Sinha","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026091805312949500_ofag497-B27","doi-asserted-by":"crossref","first-page":"e0166333","DOI":"10.1371\/journal.pone.0166333","article-title":"Nutritional status and tuberculosis risk in adult and pediatric household contacts","volume":"11","author":"Aibana","year":"2016","journal-title":"PLoS One"},{"key":"2026091805312949500_ofag497-B28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.puhe.2020.06.054","article-title":"Systematic analysis for the relationship between obesity and tuberculosis","volume":"186","author":"Badawi","year":"2020","journal-title":"Public Health"},{"key":"2026091805312949500_ofag497-B29","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3389\/fimmu.2018.02741","article-title":"Leptin functions in infectious diseases","volume":"9","author":"Maurya","year":"2018","journal-title":"Front Immunol"},{"key":"2026091805312949500_ofag497-B30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026091805312949500_ofag497-B31","doi-asserted-by":"crossref","first-page":"739766","DOI":"10.3389\/fnut.2021.739766","article-title":"Body mass index, diabetes, and risk of Tuberculosis: a retrospective cohort study","volume":"8","author":"Choi","year":"2021","journal-title":"Front Nutr"},{"key":"2026091805312949500_ofag497-B32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.5588\/ijtld.19.0094","article-title":"Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort","volume":"23","author":"Soh","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026091805312949500_ofag497-B33","author":"Franco"},{"key":"2026091805312949500_ofag497-B34","first-page":"CD016013","article-title":"Diabetes as a risk factor for tuberculosis disease","volume":"8","author":"Franco","year":"2024","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag497\/70972601\/ofag497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag497\/70972601\/ofag497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:31:38Z","timestamp":1789723898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag497\/8786391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag497","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"ofag497"}}